873814-86-9

Upstream product

• 873814-85-8 1-(2,5-difluorophenyl)-3-phenyl-6-(tetrahydro-2H-pyran-2-yloxy)hex-2-en-1-one 
• 104-15-4 toluene-4-sulfonic acid 
• 75-36-5 acetyl chloride 

Downstream Products

• 873805-95-9 3-[(5S)-1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]propan-1-ol 
• 912917-36-3 3-{3-((5S)-1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl)propanyl}-(4S)-methyl-(5R)-phenyl-1,3-oxazolidin-2-one 
• 912917-35-2 3-[(5S)-1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]-propanoic acid 

Relevant academic research and scientific papers

MITOTIC KINESIN INHIBITORS

The present invention relates to fluorinated dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to

PRODRUGS OF MITOTIC KINESIN INHIBITORS

The present invention relates to prodrugs of dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to

MITOTIC KINESIN INHIBITORS

The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to composition